Clinical Data Pfizer, BioNTech Halt Large US COVID-19 Vaccine Trial Over Slow Enrollment BioSpaceCOVID-19 partners Pfizer and BioNTech have been unable to recruit healthy adults aged 50 to 64 fast enough to deliver relevant post-marketing data.Clinical DataInfectious DiseaseRead full story pharminent April 2, 2026 (Last updated: April 2, 2026) BioSpace COVID-19 partners Pfizer and BioNTech have been unable to recruit healthy adults aged 50 to 64 fast enough to deliver relevant post-marketing data. Clinical DataInfectious DiseaseRead full story Post navigation Previous: AZ claims another win for Imfinzi in frontline liver cancerNext: Pharma’s Reluctance To Serve Europe To Dodge MFN Drug Pricing Is Chilling Related Stories Clinical Data Novo Nordisk starts trialing lower maintenance doses of oral Wegovy pharminent August 21, 2026 Clinical Data Cancer vaccine win restores Wall Street’s faith in Moderna pharminent August 20, 2026 Clinical Data New Taiho, Cullian data heats up lung cancer drug battle pharminent August 13, 2026
